Jadenu Interactions
There are 598 drugs known to interact with Jadenu (deferasirox), along with 6 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 206 are major, 379 are moderate, and 13 are minor.
- View all 598 medications that may interact with Jadenu
- View Jadenu alcohol/food interactions (2)
- View Jadenu disease interactions (6)
Most frequently checked interactions
View interaction reports for Jadenu (deferasirox) and the medicines listed below.
- Actemra (tocilizumab)
- Adempas (riociguat)
- Afinitor (everolimus)
- Ambien (zolpidem)
- amitriptyline
- Aralast NP (alpha 1-proteinase inhibitor)
- Aranesp (darbepoetin alfa)
- baclofen
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- biotin
- Bosulif (bosutinib)
- Eliquis (apixaban)
- folic acid
- furosemide
- gabapentin
- Gleevec (imatinib)
- hydroxyurea
- Jakafi (ruxolitinib)
- metformin
- Neupogen (filgrastim)
- pantoprazole
- Promacta (eltrombopag)
- Seroquel (quetiapine)
- trazodone
- Vidaza (azacitidine)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
Jadenu alcohol/food interactions
There are 2 alcohol/food interactions with Jadenu (deferasirox).
Jadenu disease interactions
There are 6 disease interactions with Jadenu (deferasirox) which include:
- bone marrow suppression
- dermatologic toxicities
- hepatic impairment
- renal dysfunction
- auditory and ocular abnormalities
- GI complication
Report options
QR code containing a link to this page
More about Jadenu (deferasirox)
- Jadenu consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: chelating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
